Trials / Completed
CompletedNCT01005719
Study to Compare Gastric Inhibition of Two Proton Pump Inhibitors (CL2008-18)(P07815)(COMPLETED)
Randomized, Crossover, Pharmacodynamic Study Comparing the Effects of Two Proton Pump Inhibitors
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 63 (actual)
- Sponsor
- Bayer · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This study will determine differences between Proton Pump Inhibitors (PPI) formulations relative to their effects on gastric acidity.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Zegerid | Zegerid (20 mg omeprazole/ 1100 mg sodium bicarbonate) taken with approximately 2 oz of water once daily for 7 days. |
| DRUG | Prevacid® | Prevacid (15 mg lansoprazole) taken with approximately 2 oz of water once daily for 7 days. |
Timeline
- Start date
- 2009-09-01
- Primary completion
- 2010-01-01
- Completion
- 2010-01-01
- First posted
- 2009-11-02
- Last updated
- 2015-03-11
- Results posted
- 2011-01-28
Source: ClinicalTrials.gov record NCT01005719. Inclusion in this directory is not an endorsement.